Cargando…

Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents

Detalles Bibliográficos
Autores principales: Goel, Shipra, Segal, Brahm, Griffiths, Elizabeth A., Hernandez-Ilizaliturri, Francisco, Torka, Pallawi, Cortese, Matthew J, Ghione, Paola, Nemeth, Michael J., Muhitch, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665258/
http://dx.doi.org/10.1182/blood-2022-170369
_version_ 1784831251826343936
author Goel, Shipra
Segal, Brahm
Griffiths, Elizabeth A.
Hernandez-Ilizaliturri, Francisco
Torka, Pallawi
Cortese, Matthew J
Ghione, Paola
Nemeth, Michael J.
Muhitch, Jason
author_facet Goel, Shipra
Segal, Brahm
Griffiths, Elizabeth A.
Hernandez-Ilizaliturri, Francisco
Torka, Pallawi
Cortese, Matthew J
Ghione, Paola
Nemeth, Michael J.
Muhitch, Jason
author_sort Goel, Shipra
collection PubMed
description
format Online
Article
Text
id pubmed-9665258
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96652582022-11-16 Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents Goel, Shipra Segal, Brahm Griffiths, Elizabeth A. Hernandez-Ilizaliturri, Francisco Torka, Pallawi Cortese, Matthew J Ghione, Paola Nemeth, Michael J. Muhitch, Jason Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665258/ http://dx.doi.org/10.1182/blood-2022-170369 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Abstracts
Goel, Shipra
Segal, Brahm
Griffiths, Elizabeth A.
Hernandez-Ilizaliturri, Francisco
Torka, Pallawi
Cortese, Matthew J
Ghione, Paola
Nemeth, Michael J.
Muhitch, Jason
Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
title Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
title_full Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
title_fullStr Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
title_full_unstemmed Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
title_short Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
title_sort evaluation of antibody and t cell responses to covid-19 vaccination in patients with lymphoid malignancies receiving b cell-depleting agents
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665258/
http://dx.doi.org/10.1182/blood-2022-170369
work_keys_str_mv AT goelshipra evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents
AT segalbrahm evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents
AT griffithselizabetha evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents
AT hernandezilizaliturrifrancisco evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents
AT torkapallawi evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents
AT cortesematthewj evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents
AT ghionepaola evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents
AT nemethmichaelj evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents
AT muhitchjason evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents